From: margaret [margaret@prismnet.com]
Sent: Friday, March 02, 2001 6:20 PM
To: fdadockets@oc.fda.gov
Subject: Docket No. 00N-0989

Docket No. 00N-0989
Dockets Management Branch
Food and Drug Administration
5630 Fishers Lane
Room 10-61 HFA-305
Rockville, MD 20852

Dear FDA: 

A proposed rule from the Food and Drug Administration (FDA) would
provide public access to study
design and safety information on all new or ongoing clinical trials
involving either gene therapy or
xenotransplantation. Both are potentially dangerous areas that the
public should know about.

I feel that it is in the public interest that this rule be adopted. The
public has a right to have access to this information.

I support this rule for the following reasons, among others:

The FDA must assume the sole responsibility for summarizing and
distributing information submitted
by the research sponsors, rather than leave it to the sponsors'
discretion. 

Moreover, the U.S. government should stop funding xenotransplantation
research. 

Margaret Weston
6810 Deatonhill Dr. #303
Austin Texas 78745